フィリピン - 英語 - FDA (Food And Drug Administration)

norpharm ventures, inc. - ferrous sulfate capsule , vitamins b complex , vitamin c - hematinic capsule - ferrous sulfate dried 200mg / folic acid 400mcg / thiamine hci (vitamin b1) 2mg/riboflavin (vitamin b2) 2mg/pyrodoxine hci (vitamin b6) 2mg/cyanocobalamin (vitamin b12 10mcg/ascorbic acid (vitamin c) 100mg /nicotinamide 20mg

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

avion pharmaceuticals, llc - ferrous bisglycinate (unii: sfw1d987qv) (ferrous cation - unii:gw89581owr), ferrous asparto glycinate (unii: h7426rgb3l) (ferrous cation - unii:gw89581owr), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), biotin (unii: 6so6u10h04) (biotin - unii:6so6u10h04), cupric oxide (unii: v1 - ferrous cation 36.7 mg - indications: feriva fa ® is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency. contraindications: feriva fa ® is contraindicated in patients with a known hypersensitivity to any of the ingredients. hemochromatosis and hemosiderosis are contraindicated to iron therapy. pediatric use: safety and effectiveness have not been studied in pediatric patients.

バングラデシュ - 英語 - DGDA (Directorate General of Drug Administration)

advanced chemical industries limited - ferrous sulphate + folic acid + zinc - pellets - 150 mg + 500 mcg + 61.8 mg

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

acella pharmaceuticals, llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), calcium (unii: sy7q814vup) (calcium - unii:sy7q814vup), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), pyridoxine (unii: kv2jz1bi6z) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), doconexent (unii: zad9okh9jc) (doconexent - unii:zad9okh9jc) - ascorbic acid 28 mg - pnv-dha + docusate is a prescription prenatal/postnatal multivitamin/multimineral softgel with dha. each softgel is red in color and imprinted with “323” on one side. † daily value (dv) not established. bovine gelatin, glycerin, soybean oil, soy lecithin, purified water, yellow beeswax, fd&c red # 40, titanium dioxide, orange cream flavor, ethyl vanillin, fd&c yellow # 6, and fd&c blue #1. contains soy. pnv-dha + docusate is a multivitamin/mineral prescription dietary supplement indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

バングラデシュ - 英語 - DGDA (Directorate General of Drug Administration)

popular pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 400 mcg

バングラデシュ - 英語 - DGDA (Directorate General of Drug Administration)

sharif pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 200 mcg

バングラデシュ - 英語 - DGDA (Directorate General of Drug Administration)

sharif pharmaceuticals ltd. - ferrous fumarate + folic acid - tablet - 200 mg + 400 mcg

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

amella pharma, llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), methylcobalamin (unii: br1sn1js2w) (methylcobalamin - unii:br1sn1js2w), ferrous fumarate (unii: r5l488ry0q) (ferrous cation - unii:gw89581owr), zinc citrate (unii: k72i3dex9b) (zinc cation - unii:13s1s8sf37) - feonyx should not be used by patients with a known hypersensitivity to any of the listed ingredients. all iron compounds are contraindicated in patients with hemochromatosis, hemosiderosis, or hemolytic anemias. precautions: general: take 2 hours after meals. do not exceed recommended dose. discontinue use if symptoms of intolerance appear. the type of anemia and the underlying cause or causes should be determined before starting therapy with feonyx tablets. ensure hgb, hct, reticulocyte count are determined before starting therapy and periodically thereafter during prolonged treatment. periodically review therapy to determine if it needs to be continued without change or if a dose change is indicated. since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible. folic acid: folic acid alone is an improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin b12 is deficient. f

ウガンダ - 英語 - National Drug Authority

laborate pharmaceuticals india limited - ferrous sulphate + folic acid - oral solid ordinary film-coated tablets - 60 mg + 0.6 mg

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

sterling winthrop (nz) ltd (now skb nz or sanofi winthrop) - ferrous gluconate dihydrate 300mg; folic acid 150ug - tablet - 300mg/150µg - active: ferrous gluconate dihydrate 300mg folic acid 150ug